{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:40:48Z","timestamp":1794649248596,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T00:00:00Z","timestamp":1694649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-023-00889-6","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T12:03:52Z","timestamp":1694693032000},"page":"1673-1684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6209-0493","authenticated-orcid":false,"given":"Wenwen","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9824-9570","authenticated-orcid":false,"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunna","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Gbahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Cecon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Houz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Katsonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7588-9209","authenticated-orcid":false,"given":"Alan","family":"Hegron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiran","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-8749","authenticated-orcid":false,"given":"Mathilde","family":"Boissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5020-5379","authenticated-orcid":false,"given":"Mehdi","family":"Derhourhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Marre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-413X","authenticated-orcid":false,"given":"Beverley","family":"Balkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-0784","authenticated-orcid":false,"given":"Philippe","family":"Froguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-337X","authenticated-orcid":false,"given":"Raphael","family":"Scharfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lichtarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-2678","authenticated-orcid":false,"given":"Julie","family":"Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bonnefond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-8377","authenticated-orcid":false,"given":"Jianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-1750","authenticated-orcid":false,"given":"Ralf","family":"Jockers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"889_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","volume":"30","author":"TD Muller","year":"2019","unstructured":"Muller, T. D. et al. Glucagon-like peptide 1 (GLP-1). Mol. Metab. 30, 72\u2013130 (2019).","journal-title":"Mol. Metab."},{"key":"889_CR2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1124\/pr.115.011395","volume":"68","author":"C Graaf","year":"2016","unstructured":"Graaf, C. et al. Glucagon-like peptide-1 and its class B G-protein-coupled receptors: a long march to therapeutic successes. Pharm. Rev. 68, 954\u20131013 (2016).","journal-title":"Pharm. Rev."},{"key":"889_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature22394","volume":"546","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature 546, 248\u2013253 (2017).","journal-title":"Nature"},{"key":"889_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1124\/mol.111.072884","volume":"80","author":"C Koole","year":"2011","unstructured":"Koole, C. et al. Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutation. Mol. Pharmacol. 80, 486\u2013497 (2011).","journal-title":"Mol. Pharmacol."},{"key":"889_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1210\/me.2013-1116","volume":"27","author":"C Koole","year":"2013","unstructured":"Koole, C. et al. Minireview: signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery. Mol. Endocrinol. 27, 1234\u20131244 (2013).","journal-title":"Mol. Endocrinol."},{"key":"889_CR6","doi-asserted-by":"publisher","first-page":"108044","DOI":"10.1016\/j.pharmthera.2021.108044","volume":"234","author":"T Liu","year":"2022","unstructured":"Liu, T., Ji, R. L. & Tao, Y. X. Naturally occurring mutations in G-protein-coupled receptors associated with obesity and type 2 diabetes mellitus. Pharmacol. Ther. 234, 108044 (2022).","journal-title":"Pharmacol. Ther."},{"key":"889_CR7","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1101\/gr.176214.114","volume":"24","author":"P Katsonis","year":"2014","unstructured":"Katsonis, P. & Lichtarge, O. A formal perturbation equation between genotype and phenotype determines the evolutionary action of protein-coding variations on fitness. Genome Res 24, 2050\u20132058 (2014).","journal-title":"Genome Res"},{"key":"889_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/jmbi.1996.0167","volume":"257","author":"O Lichtarge","year":"1996","unstructured":"Lichtarge, O., Bourne, H. R. & Cohen, F. E. An evolutionary trace method defines binding surfaces common to protein families. J. Mol. Biol. 257, 342\u2013358 (1996).","journal-title":"J. Mol. Biol."},{"key":"889_CR9","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.cell.2016.05.023","volume":"165","author":"D Wootten","year":"2016","unstructured":"Wootten, D. et al. The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism. Cell 165, 1632\u20131643 (2016).","journal-title":"Cell"},{"key":"889_CR10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/s42255-020-00294-3","volume":"2","author":"A Bonnefond","year":"2020","unstructured":"Bonnefond, A. et al. Pathogenic variants in actionable MODY genes are associated with type 2 diabetes. Nat. Metab. 2, 1126\u20131134 (2020).","journal-title":"Nat. Metab."},{"key":"889_CR11","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1042\/BCJ20160476","volume":"473","author":"J Naylor","year":"2016","unstructured":"Naylor, J. et al. Use of CRISPR\/Cas9-engineered INS-1 pancreatic beta cells to define the pharmacology of dual GIPR\/GLP-1R agonists. Biochem. J. 473, 2881\u20132891 (2016).","journal-title":"Biochem. J."},{"key":"889_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14309-w","volume":"11","author":"J Ast","year":"2020","unstructured":"Ast, J. et al. Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics. Nat. Commun. 11, 467 (2020).","journal-title":"Nat. Commun."},{"key":"889_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ng.1053","volume":"44","author":"A Bonnefond","year":"2012","unstructured":"Bonnefond, A. et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat. Genet. 44, 297\u2013301 (2012).","journal-title":"Nat. Genet."},{"key":"889_CR14","doi-asserted-by":"publisher","first-page":"eaan6622","DOI":"10.1126\/scisignal.aan6622","volume":"11","author":"A Karamitri","year":"2018","unstructured":"Karamitri, A. et al. Type 2 diabetes-associated variants of the MT(2) melatonin receptor affect distinct modes of signaling. Sci. Signal. 11, eaan6622 (2018).","journal-title":"Sci. Signal."},{"key":"889_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S2213-8587(22)00392-8","volume":"11","author":"L Folon","year":"2023","unstructured":"Folon, L. et al. Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study. Lancet Diabetes Endocrinol. 11, 182\u2013190 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"889_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03941-2","volume":"9","author":"B Jones","year":"2018","unstructured":"Jones, B. et al. Targeting GLP-1 receptor trafficking to improve agonist efficacy. Nat. Commun. 9, 1602 (2018).","journal-title":"Nat. Commun."},{"key":"889_CR17","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/oby.22794","volume":"28","author":"RF Kushner","year":"2020","unstructured":"Kushner, R. F. et al. Semaglutide 2.4\u2009mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity 28, 1050\u20131061 (2020).","journal-title":"Obesity"},{"key":"889_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1073\/pnas.0605701104","volume":"104","author":"LB Knudsen","year":"2007","unstructured":"Knudsen, L. B. et al. Small-molecule agonists for the glucagon-like peptide 1 receptor. Proc. Natl Acad. Sci. USA 104, 937\u2013942 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"889_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1124\/mol.110.065664","volume":"78","author":"C Koole","year":"2010","unstructured":"Koole, C. et al. Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening. Mol. Pharmacol. 78, 456\u2013465 (2010).","journal-title":"Mol. Pharmacol."},{"key":"889_CR20","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1124\/mol.112.084525","volume":"83","author":"D Wootten","year":"2013","unstructured":"Wootten, D. et al. Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands. Mol. Pharmacol. 83, 822\u2013834 (2013).","journal-title":"Mol. Pharmacol."},{"key":"889_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","volume":"398","author":"J Rosenstock","year":"2021","unstructured":"Rosenstock, J. et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet 398, 143\u2013155 (2021).","journal-title":"Lancet"},{"key":"889_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/bph.15446","volume":"179","author":"F Malik","year":"2022","unstructured":"Malik, F. & Li, Z. Non-peptide agonists and positive allosteric modulators of glucagon-like peptide-1 receptors: alternative approaches for treatment of type 2 diabetes. Br. J. Pharmacol. 179, 511\u2013525 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"889_CR23","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41589-020-0589-7","volume":"16","author":"AB Bueno","year":"2020","unstructured":"Bueno, A. B. et al. Structural insights into probe-dependent positive allosterism of the GLP-1 receptor. Nat. Chem. Biol. 16, 1105\u20131110 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"889_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/bph.15497","volume":"179","author":"B Jones","year":"2022","unstructured":"Jones, B. The therapeutic potential of GLP-1 receptor biased agonism. Br. J. Pharmacol. 179, 492\u2013510 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"889_CR25","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1073\/pnas.0710402105","volume":"105","author":"N Sonoda","year":"2008","unstructured":"Sonoda, N. et al. Beta-arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc. Natl Acad. Sci. USA 105, 6614\u20136619 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"889_CR26","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1074\/jbc.M109.067207","volume":"285","author":"J Quoyer","year":"2010","unstructured":"Quoyer, J. et al. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1\/2 activation in pancreatic beta-cells. J. Biol. Chem. 285, 1989\u20132002 (2010).","journal-title":"J. Biol. Chem."},{"key":"889_CR27","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41591-019-0622-0","volume":"25","author":"M Baron","year":"2019","unstructured":"Baron, M. et al. Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension. Nat. Med. 25, 1733\u20131738 (2019).","journal-title":"Nat. Med."},{"key":"889_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02257-x","volume":"8","author":"AM Schonegge","year":"2017","unstructured":"Schonegge, A. M. et al. Evolutionary action and structural basis of the allosteric switch controlling \u03b22AR functional selectivity. Nat. Commun. 8, 2169 (2017).","journal-title":"Nat. Commun."},{"key":"889_CR29","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1038\/emboj.2011.178","volume":"30","author":"E Lima-Fernandes","year":"2011","unstructured":"Lima-Fernandes, E. et al. Distinct functional outputs of PTEN signalling are controlled by dynamic association with beta-arrestins. EMBO J. 30, 2557\u20132568 (2011).","journal-title":"EMBO J."},{"key":"889_CR30","doi-asserted-by":"publisher","first-page":"101060","DOI":"10.1016\/j.molmet.2020.101060","volume":"42","author":"C Berthault","year":"2020","unstructured":"Berthault, C., Staels, W. & Scharfmann, R. Purification of pancreatic endocrine subsets reveals increased iron metabolism in beta cells. Mol. Metab. 42, 101060 (2020).","journal-title":"Mol. Metab."},{"key":"889_CR31","doi-asserted-by":"publisher","first-page":"16762","DOI":"10.1074\/jbc.M802069200","volume":"283","author":"JL Guillaume","year":"2008","unstructured":"Guillaume, J. L. et al. The PDZ protein mupp1 promotes Gi coupling and signaling of the Mt1 melatonin receptor. J. Biol. Chem. 283, 16762\u201316771 (2008).","journal-title":"J. Biol. Chem."},{"key":"889_CR32","doi-asserted-by":"publisher","first-page":"e12641","DOI":"10.1111\/jpi.12641","volume":"68","author":"M Chen","year":"2020","unstructured":"Chen, M. et al. Melatonin MT1 and MT2 receptor ERK signaling is differentially dependent on Gi\/o and Gq\/11 proteins. J. Pineal Res. 68, e12641 (2020).","journal-title":"J. Pineal Res."},{"key":"889_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/gepi.21717","volume":"37","author":"J Sun","year":"2013","unstructured":"Sun, J., Zheng, Y. & Hsu, L. A unified mixed-effects model for rare-variant association in sequencing studies. Genet. Epidemiol. 37, 334\u2013344 (2013).","journal-title":"Genet. Epidemiol."},{"key":"889_CR34","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.ajhg.2016.09.014","volume":"99","author":"KJ Galinsky","year":"2016","unstructured":"Galinsky, K. J., Loh, P. R., Mallick, S., Patterson, N. J. & Price, A. L. Population structure of UK Biobank and ancient eurasians reveals adaptation at genes influencing blood pressure. Am. J. Hum. Genet 99, 1130\u20131139 (2016).","journal-title":"Am. J. Hum. Genet"},{"key":"889_CR35","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1476-5381.2012.02223.x","volume":"168","author":"T Kenakin","year":"2013","unstructured":"Kenakin, T. New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2. Br. J. Pharmacol. 168, 554\u2013575 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"889_CR36","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1111\/bph.13950","volume":"175","author":"E Cecon","year":"2018","unstructured":"Cecon, E., Oishi, A. & Jockers, R. Melatonin receptors: molecular pharmacology and signalling in the context of system bias. Br. J. Pharmacol. 175, 3263\u20133280 (2018).","journal-title":"Br. J. Pharmacol."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-023-00889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-023-00889-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-023-00889-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T19:03:36Z","timestamp":1698001416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-023-00889-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1038\/s42255-023-00889-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2114208\/v1","asserted-by":"object"}]},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,14]]},"assertion":[{"value":"28 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}